Brent Lalomia
CIK 1921560 · View on SEC EDGAR ↗
Insider
First SEC filing: June 21, 2022 · Latest: March 18, 2026
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 25 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 6, 2026 | CNMD | M | 75 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| March 6, 2026 | CNMD | F | 26 | $39.90 | $1,037 | 915 Direct | -2.76% | Disposed | 28.0% (price as of 2026-08-21) |
| March 6, 2026 | CNMD | M | 75 | — | — | 941 Direct | +8.66% | Acquired | (price as of 2026-08-21) |
| March 2, 2026 | CNMD | A | 17,198 | — | — | 17,198 Direct | — | Acquired | (price as of 2026-08-21) |
| March 2, 2026 | CNMD | A | 11,322 | — | — | 11,322 Direct | — | Acquired | (price as of 2026-08-21) |
| March 2, 2026 | CNMD | A | 9,554 | — | — | 9,554 Direct | — | Acquired | (price as of 2026-08-21) |
| March 7, 2025 | CNMD | M | 75 | — | — | 75 Direct | -50.00% | Disposed | (price as of 2026-08-21) |
| March 7, 2025 | CNMD | F | 26 | $62.74 | $1,631 | 1,006 Direct | -2.52% | Disposed | -18.6% (price as of 2026-08-21) |
| March 7, 2025 | CNMD | M | 75 | — | — | 1,032 Direct | +7.84% | Acquired | (price as of 2026-08-21) |
| March 3, 2025 | CNMD | A | 26,895 | — | — | 26,895 Direct | — | Acquired | (price as of 2026-08-21) |
| March 7, 2024 | CNMD | M | 75 | — | — | 150 Direct | -33.33% | Disposed | (price as of 2026-08-21) |
| March 7, 2024 | CNMD | F | 26 | $85.00 | $2,210 | 957 Direct | -2.64% | Disposed | -39.9% (price as of 2026-08-21) |
| March 7, 2024 | CNMD | M | 75 | — | — | 983 Direct | +8.26% | Acquired | (price as of 2026-08-21) |
| March 1, 2024 | CNMD | A | 18,988 | — | — | 18,988 Direct | — | Acquired | (price as of 2026-08-21) |
| June 17, 2023 | CNMD | M | 250 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| June 17, 2023 | CNMD | F | 71 | $135.64 | $9,630 | 908 Direct | -7.25% | Disposed | -62.3% (price as of 2026-08-21) |
| June 17, 2023 | CNMD | M | 250 | — | — | 979 Direct | +34.29% | Acquired | (price as of 2026-08-21) |
| March 7, 2023 | CNMD | M | 75 | — | — | 225 Direct | -25.00% | Disposed | (price as of 2026-08-21) |
| March 7, 2023 | CNMD | F | 26 | $95.32 | $2,478 | 729 Direct | -3.44% | Disposed | -46.4% (price as of 2026-08-21) |
| March 7, 2023 | CNMD | M | 75 | — | — | 755 Direct | +11.03% | Acquired | (price as of 2026-08-21) |
| March 1, 2023 | CNMD | A | 12,317 | — | — | 12,317 Direct | — | Acquired | (price as of 2026-08-21) |
| June 30, 2022 | CNMD | L | 1 | $97.69 | $98 | 679 Direct | +0.15% | Acquired | -47.7% (price as of 2026-08-21) |
| June 17, 2022 | CNMD | M | 250 | — | — | 250 Direct | -50.00% | Disposed | (price as of 2026-08-21) |
| June 17, 2022 | CNMD | F | 72 | $88.93 | $6,403 | 678 Direct | -9.60% | Disposed | -42.6% (price as of 2026-08-21) |
| June 17, 2022 | CNMD | M | 250 | — | — | 750 Direct | +50.00% | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 6, 2026 | CNMD | RSUs (Restricted Stock Units) | Common Stock (75) | $0.00 | March 7, 2032 | 75 | Disposed |
| March 2, 2026 | CNMD | RSUs (Restricted Stock Units) | Common Stock | $0.00 | March 2, 2036 | 17,198 | Acquired |
| March 2, 2026 | CNMD | Options To Purchase Common Stock | Common Stock (11,322) | $45.79 | March 2, 2036 | 11,322 | Acquired |
| March 2, 2026 | CNMD | RSUs (Restricted Stock Units) | Common Stock (9,554) | $0.00 | March 2, 2036 | 9,554 | Acquired |
| March 7, 2025 | CNMD | RSUs (Restricted Stock Units) | Common Stock (75) | $0.00 | March 7, 2032 | 75 | Disposed |
| March 3, 2025 | CNMD | Options To Purchase Common Stock | Common Stock (26,895) | $58.33 | March 3, 2035 | 26,895 | Acquired |
| March 7, 2024 | CNMD | Rsus (restricted Stock Units) | Common Stock (75) | $0.00 | March 7, 2032 | 75 | Disposed |
| March 1, 2024 | CNMD | Options To Purchase Common Stock | Common Stock (18,988) | $79.95 | March 1, 2034 | 18,988 | Acquired |
| June 17, 2023 | CNMD | Rsus (restricted Stock Units) | Common Stock (250) | $0.00 | June 17, 2029 | 250 | Disposed |
| March 7, 2023 | CNMD | Rsus (restricted Stock Units) | Common Stock (75) | $0.00 | March 7, 2032 | 75 | Disposed |
| March 1, 2023 | CNMD | Options To Purchase Common Stock | Common Stock (12,317) | $96.16 | March 1, 2033 | 12,317 | Acquired |
| June 17, 2022 | CNMD | Rsus (restricted Stock Units) | Common Stock (250) | $0.00 | June 17, 2029 | 250 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 7 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 21, 2022 | CNMD | Rsus (restricted Stock Units) [F1]→ Common Stock (1,000) | 1,000 | Direct |
| June 21, 2022 | CNMD | Rsus (restricted Stock Units) [F3]→ Common Stock (300) | 300 | Direct |
| April 8, 2022 | CNMD | Common Stock | 500 | Direct |
| April 8, 2022 | CNMD | Options To Purchase Common Stock→ Common Stock (2,500) | 2,500 | Direct |
| April 8, 2022 | CNMD | Options To Purchase Common Stock→ Common Stock (4,000) | 4,000 | Direct |
| April 8, 2022 | CNMD | Options To Purchase Common Stock→ Common Stock (4,000) | 4,000 | Direct |
| April 8, 2022 | CNMD | Options To Purchase Common Stock→ Common Stock (8,000) | 8,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CNMD
President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | — | $50,000 | — | — | $276,073 | — | $37,245 | $1,662,776 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.